Pomegranate: a fruit that ameliorates metabolic syndrome (Q38051576)

27 August 2017

Pomegranate: a fruit that ameliorates metabolic syndrome (English)

1 reference

27 August 2017

1 reference

Alois Jungbauer

2

0 references

author name string

Svjetlana Medjakovic

series ordinal

1

1 reference

27 August 2017

12 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

4

1 reference

27 August 2017

19-39

1 reference

27 August 2017

1

1 reference

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons

27 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punica granatum: heuristic treatment for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice: a heart-healthy fruit juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Projecting the future diabetes population size and related costs for the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Role of selected Indian plants in management of type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Total phenolic distribution of juice, peel, and seed extracts of four pomegranate cultivars

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Comparison of the polyphenolic composition and antioxidant activity of European commercial fruit juices

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Carbonic anhydrase inhibitors from the pericarps of Punica granatum L

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punicafolin, an ellagitannin from the leaves of Punica granatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Volatile composition and sensory quality of Spanish pomegranates (Punica granatum L.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Sensory and physicochemical characterization of juices made with pomegranate and blueberries, blackberries, or raspberries

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Fatty acids from Tunisian and Chinese pomegranate (Punica granatum L.) seeds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Antioxidant capacity and lipid characterization of six Georgia-grown pomegranate cultivars

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate oil analysis with emphasis on MALDI-TOF/MS triacylglycerol fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Green tea and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Climate effects on anthocyanin accumulation and composition in the pomegranate (Punica granatum L.) fruit arils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Evolution of juice anthocyanins during ripening of new selected pomegranate ( Punica granatum ) clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Color, sugars and organic acids composition in aril juices and peel homogenates prepared from different pomegranate accessions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Environmental conditions affect the color, taste, and antioxidant capacity of 11 pomegranate accessions' fruits

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Transport behavior of ellagic acid of pomegranate leaf tannins and its correlation with total cholesterol alteration in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Assessment of the genotoxic risk of Punica granatum L. (Punicaceae) whole fruit extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Toxicological evaluation of pomegranate seed oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ethiopian traditional herbal drugs. Part I: Studies on the toxicity and therapeutic activity of local taenicidal medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Safety evaluation of an oak-flavored milk powder containing ellagitannins upon oral administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate (Punica granatum) juices: chemical composition, micronutrient cations, and antioxidant capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate extract mouth rinsing effects on saliva measures relevant to gingivitis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The adipocyte as an endocrine organ in the regulation of metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effects of feeding polyphenols from pomegranate extract on health, growth, nutrient digestion, and immunocompetence of calves

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Nutritive and antioxidative potential of fresh and stored pomegranate industrial byproduct as a novel beef cattle feed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Dietary effect of pomegranate seed oil on immune function and lipid metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The three-gene paraoxonase family: physiologic roles, actions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Red wine: a source of potent ligands for peroxisome proliferator-activated receptor γ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

High density lipoprotein turnover is dependent on peroxisome proliferator-activated receptor α in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Aspirin increases apolipoprotein-A-I-mediated cholesterol efflux via enhancing expression of ATP-binding cassette transporter A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Suppressive effect of Punica granatum on the production of tumor necrosis factor (Tnf) in BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate fruit extract impairs invasion and motility in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Stimulation of osteoblastic differentiation and inhibition of interleukin-6 and nitric oxide in MC3T3-E1 cells by pomegranate ethanol extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Medicinal flowers. XXIII. New taraxastane-type triterpene, punicanolic acid, with tumor necrosis factor-alpha inhibitory activity from the flowers of Punica granatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

2-Methyl-pyran-4-one-3-O-β-D-glucopyranoside isolated from leaves of Punica granatum inhibits the TNFα-induced cell adhesion molecules expression by blocking nuclear transcription factor-κB (NF-κB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Immune-suppressive activity of punicalagin via inhibition of NFAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Ellagic Acid attenuates immunoglobulin E-mediated allergic response in mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Evaluation of the anti-inflammatory effects of ellagic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Antioxidant effect of pomegranate extract in reducing acute inflammation due to myringotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

An aqueous pomegranate peel extract inhibits neutrophil myeloperoxidase in vitro and attenuates lung inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Punica granatum peel extract protects against ionizing radiation-induced enteritis and leukocyte apoptosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate fruit extract inhibits UVB-induced inflammation and proliferation by modulating NF-κB and MAPK signaling pathways in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Bioactive lipids in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The diversity of sex steroid action: regulation of metabolism by estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Pomegranate and breast cancer: possible mechanisms of prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effect of pomegranate seed oil on serum TNF-α level in dyslipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Anthocyanins characterization of 15 Iranian pomegranate (Punica granatum L.) varieties and their variation after cold storage and pasteurization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Determination of fatty acids and total lipid content in oilseed of 25 pomegranates varieties grown in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Phytochemical characterisation for industrial use of pomegranate (Punica granatum L.) cultivars grown in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

Effects of a Pomegranate Fruit Extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO30034F

https://opencitations.net/index/api/v1/citations/10.1248/CPB.34.650

21 January 2018

1 reference

12 April 2024

Identifiers

DOI

10.1039/C2FO30034F

1 reference

27 August 2017

1 reference

PubMed ID

23060097